A summary of the latest developments from 12 studies in BTK inhibition in B-cell malignancies presented at EHA2022.

The Satellite Symposium at BSH 2022 provided expert insights into treatment options in Waldenström's macroglobulinemia (WM), the emerging role of BTKis in WM, and BTKi-associated adverse events and their management.

Report on updates in the treatment of B-cell malignancies presented at ASH 2021.

Report on treatment advances in advanced solid tumors presented at ESMO 2021.

Report on updates in the treatment of lung cancer presented at WCLC and ESMO 2021.